vs
Side-by-side financial comparison of Andersons, Inc. (ANDE) and Claritev Corp (CTEV). Click either name above to swap in a different company.
Andersons, Inc. is the larger business by last-quarter revenue ($329.5M vs $246.6M, roughly 1.3× Claritev Corp). Andersons, Inc. runs the higher net margin — 20.5% vs -32.7%, a 53.1% gap on every dollar of revenue. On growth, Claritev Corp posted the faster year-over-year revenue change (6.2% vs -2.4%). Claritev Corp produced more free cash flow last quarter ($36.4M vs $-77.1M). Over the past eight quarters, Claritev Corp's revenue compounded faster (2.5% CAGR vs -1.8%).
The Andersons, Inc. is an American agribusiness established in 1947, that began as Andersons Truck Terminal (ATT) in the 1940s for the grain industry, headquartered in Maumee, Ohio. It is a diversified company rooted in agriculture that conducts business in the commodity merchandising, renewables, and plant nutrient sectors.
ANDE vs CTEV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $329.5M | $246.6M |
| Net Profit | $67.4M | $-80.6M |
| Gross Margin | 70.3% | — |
| Operating Margin | 26.6% | -3.1% |
| Net Margin | 20.5% | -32.7% |
| Revenue YoY | -2.4% | 6.2% |
| Net Profit YoY | 49.6% | 41.6% |
| EPS (diluted) | — | $-4.88 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $329.5M | $246.6M | ||
| Q3 25 | $295.8M | $246.0M | ||
| Q2 25 | $535.0M | $241.6M | ||
| Q1 25 | $370.8M | $231.3M | ||
| Q4 24 | $337.5M | $232.1M | ||
| Q3 24 | $231.9M | $230.5M | ||
| Q2 24 | $492.5M | $233.5M | ||
| Q1 24 | $341.4M | $234.5M |
| Q4 25 | $67.4M | $-80.6M | ||
| Q3 25 | $20.1M | $-69.8M | ||
| Q2 25 | $7.9M | $-62.6M | ||
| Q1 25 | $284.0K | $-71.3M | ||
| Q4 24 | $45.1M | $-138.0M | ||
| Q3 24 | $27.4M | $-391.4M | ||
| Q2 24 | $36.0M | $-576.7M | ||
| Q1 24 | $5.6M | $-539.7M |
| Q4 25 | 70.3% | — | ||
| Q3 25 | 57.8% | — | ||
| Q2 25 | 29.6% | — | ||
| Q1 25 | 41.2% | — | ||
| Q4 24 | 63.1% | — | ||
| Q3 24 | 76.4% | — | ||
| Q2 24 | 35.6% | — | ||
| Q1 24 | 37.6% | — |
| Q4 25 | 26.6% | -3.1% | ||
| Q3 25 | 8.7% | 4.1% | ||
| Q2 25 | 4.6% | 6.9% | ||
| Q1 25 | 0.9% | 4.2% | ||
| Q4 24 | 19.9% | -17.8% | ||
| Q3 24 | 26.8% | -146.7% | ||
| Q2 24 | 11.6% | -224.4% | ||
| Q1 24 | 4.1% | -207.4% |
| Q4 25 | 20.5% | -32.7% | ||
| Q3 25 | 6.8% | -28.4% | ||
| Q2 25 | 1.5% | -25.9% | ||
| Q1 25 | 0.1% | -30.8% | ||
| Q4 24 | 13.4% | -59.4% | ||
| Q3 24 | 11.8% | -169.8% | ||
| Q2 24 | 7.3% | -247.0% | ||
| Q1 24 | 1.6% | -230.1% |
| Q4 25 | — | $-4.88 | ||
| Q3 25 | $0.59 | $-4.23 | ||
| Q2 25 | $0.23 | $-3.81 | ||
| Q1 25 | $0.01 | $-4.38 | ||
| Q4 24 | $1.31 | $-8.49 | ||
| Q3 24 | $0.80 | $-24.25 | ||
| Q2 24 | $1.05 | $-35.78 | ||
| Q1 24 | $0.16 | $-33.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $98.3M | $16.8M |
| Total DebtLower is stronger | $560.0M | $4.6B |
| Stockholders' EquityBook value | $1.2B | $-173.9M |
| Total Assets | $3.7B | $4.9B |
| Debt / EquityLower = less leverage | 0.45× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $98.3M | $16.8M | ||
| Q3 25 | — | $39.2M | ||
| Q2 25 | — | $56.4M | ||
| Q1 25 | — | $23.1M | ||
| Q4 24 | $561.8M | $16.8M | ||
| Q3 24 | — | $86.6M | ||
| Q2 24 | — | $48.8M | ||
| Q1 24 | — | $58.7M |
| Q4 25 | $560.0M | $4.6B | ||
| Q3 25 | — | $4.5B | ||
| Q2 25 | — | $4.5B | ||
| Q1 25 | — | $4.5B | ||
| Q4 24 | $608.2M | $4.5B | ||
| Q3 24 | — | $4.5B | ||
| Q2 24 | — | $4.5B | ||
| Q1 24 | — | $4.5B |
| Q4 25 | $1.2B | $-173.9M | ||
| Q3 25 | $1.2B | $-101.8M | ||
| Q2 25 | $1.4B | $-39.9M | ||
| Q1 25 | $1.4B | $14.8M | ||
| Q4 24 | $1.4B | $84.0M | ||
| Q3 24 | $1.3B | $207.6M | ||
| Q2 24 | $1.3B | $603.4M | ||
| Q1 24 | $1.3B | $1.2B |
| Q4 25 | $3.7B | $4.9B | ||
| Q3 25 | $3.3B | $5.0B | ||
| Q2 25 | $3.4B | $5.1B | ||
| Q1 25 | $3.8B | $5.1B | ||
| Q4 24 | $4.1B | $5.2B | ||
| Q3 24 | $3.4B | $5.3B | ||
| Q2 24 | $3.3B | $5.7B | ||
| Q1 24 | $3.3B | $6.4B |
| Q4 25 | 0.45× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 304.87× | ||
| Q4 24 | 0.45× | 53.67× | ||
| Q3 24 | — | 21.73× | ||
| Q2 24 | — | 7.48× | ||
| Q1 24 | — | 3.85× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-6.2M | $66.3M |
| Free Cash FlowOCF − Capex | $-77.1M | $36.4M |
| FCF MarginFCF / Revenue | -23.4% | 14.8% |
| Capex IntensityCapex / Revenue | 21.5% | 12.1% |
| Cash ConversionOCF / Net Profit | -0.09× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-56.1M | $-12.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.2M | $66.3M | ||
| Q3 25 | $233.9M | $19.9M | ||
| Q2 25 | $299.3M | $61.2M | ||
| Q1 25 | $-350.0M | $-30.1M | ||
| Q4 24 | $268.8M | $-33.4M | ||
| Q3 24 | $-2.1M | $72.8M | ||
| Q2 24 | $304.4M | $18.5M | ||
| Q1 24 | $-239.6M | $49.7M |
| Q4 25 | $-77.1M | $36.4M | ||
| Q3 25 | $167.0M | $-16.3M | ||
| Q2 25 | $250.5M | $36.6M | ||
| Q1 25 | $-396.6M | $-68.9M | ||
| Q4 24 | $212.9M | $-63.8M | ||
| Q3 24 | $-40.0M | $41.1M | ||
| Q2 24 | $275.8M | $-7.0M | ||
| Q1 24 | $-266.4M | $19.2M |
| Q4 25 | -23.4% | 14.8% | ||
| Q3 25 | 56.5% | -6.6% | ||
| Q2 25 | 46.8% | 15.2% | ||
| Q1 25 | -106.9% | -29.8% | ||
| Q4 24 | 63.1% | -27.5% | ||
| Q3 24 | -17.2% | 17.8% | ||
| Q2 24 | 56.0% | -3.0% | ||
| Q1 24 | -78.0% | 8.2% |
| Q4 25 | 21.5% | 12.1% | ||
| Q3 25 | 22.6% | 14.7% | ||
| Q2 25 | 9.1% | 10.2% | ||
| Q1 25 | 12.6% | 16.8% | ||
| Q4 24 | 16.6% | 13.1% | ||
| Q3 24 | 16.3% | 13.8% | ||
| Q2 24 | 5.8% | 10.9% | ||
| Q1 24 | 7.8% | 13.0% |
| Q4 25 | -0.09× | — | ||
| Q3 25 | 11.61× | — | ||
| Q2 25 | 38.10× | — | ||
| Q1 25 | -1232.46× | — | ||
| Q4 24 | 5.96× | — | ||
| Q3 24 | -0.08× | — | ||
| Q2 24 | 8.46× | — | ||
| Q1 24 | -42.94× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ANDE
| Specialty And Primary Nutrients | $137.1M | 42% |
| Premium Ingredients | $66.1M | 20% |
| Segment Reporting Reconciling Item Other | $63.2M | 19% |
| Other | $63.1M | 19% |
CTEV
Segment breakdown not available.